Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ: DXCM )

68.48 -2.28 (-3.22%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
DexCom Inc (DXCM) Q2 2021 Earnings Call Transcript
DXCM earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
12 Stocks Moving In Thursday's After-Hours Session
Gainers Atlassian (NASDAQ: TEAM) shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued Q1 EPS and sales guidance above... 
Via Benzinga
Why DexCom's Stock Is Trading Higher Today
DexCom, Inc. (NASDAQ: DXCM) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results and issued FY21 sales guidance above estimates.... 
Via Benzinga
Recap: DexCom Q2 Earnings
Shares of DexCom (NASDAQ:DXCM) rose 3.7% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 3.80% year over year to $0.... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Erytech Pharma (NASDAQ:ERYP) sha... 
Via Benzinga
Stocks That Hit 52-Week Highs On Thursday
Thursday's morning session saw 167 companies set new 52-week highs. Points of Interest: ASML Holding (NASDAQ:ASML) was the largest company by market cap to set a new... 
Via Benzinga
Dexcom Reports Second Quarter 2021 Financial Results
From DexCom, Inc.
Via Business Wire
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures Product Safety
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start... 
Via Benzinga
Exposures Product Safety
FDA Clears Dexcom Real-Time APIs for Third-Party Apps and Devices
From DexCom, Inc.
Via Business Wire
Dexcom Schedules Second Quarter 2021 Earnings Release and Conference Call for July 29, 2021 at 4:30 p.m. Eastern Time
From DexCom, Inc.
Via Business Wire
Dexcom CGM Plays Starring Role at 81st Scientific Sessions of the American Diabetes Association
From DexCom, Inc.
Via Business Wire
DexCom, Nick Jonas and Leading Diabetes Nonprofits Launch Initiative to Help Improve the Lives of People With Diabetes
From DexCom
Via Business Wire
Endurance Athlete Sébastien Sasseville to Ride Across Canada in Support of JDRF’s Access For All Campaign
From Dexcom, Inc.
Via Business Wire
Cramer Weighs In On Senseonics Holdings, Celsius And Contextlogic
On CNBC's "Mad Money Lightning Round," Jim Cramer said Senseonics Holdings Inc (NYSE: SENS) competes with DexCom, Inc. (NASDAQ: DXCM) and Abbott Laboratories (NYSE:... 
Via Benzinga
British Columbia First Province to Cover Dexcom G6 Continuous Glucose Monitoring System for People With Type 1 and Type 2 Diabetes on Intensive Insulin Therapy
From Dexcom, Inc.
Via Business Wire
Why Senseonics Shares Are Rocketing Higher After Hours Thursday
Study results from a glucose monitoring company were reported after market close Thursday. What Happened: Medical technology company Senseonics Holdings (NYSE: SENS) reported... 
Via Benzinga
Dexcom Looks to the Future of Continuous Glucose Monitoring
From DexCom, Inc.
Via Business Wire
Where DexCom Stands With Analysts
Analysts have provided the following ratings for DexCom (NASDAQ:DXCM) within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 2 0 0... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 28, 2021
Upgrades For Delek US Holdings Inc (NYSE:DK), Tudor Pickering upgraded the previous rating of Hold to Buy. For the first quarter, Delek US Hldgs had an EPS of $1.69,... 
Via Benzinga
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021
Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to... 
Via Benzinga
Why DexCom Stock Jumped Today
No news was good news for the healthcare stock. 
Via The Motley Fool
3 Top Healthcare Stocks to Buy Right Now
These three healthcare stocks have proven that growth and long-term trends are on their side. 
Via The Motley Fool
These 7 Medical Stocks Are Breaking Down — The Sell Rule You Should Know
Former high-flyers Dexcom and Tandem Diabetes are among seven health care stocks breaking down right now, according to MarketSmith.com. 
Via Investor's Business Daily
2 Top Growth Stocks on Sale After Earnings
For these two companies, the bull case remains intact. 
Via The Motley Fool
38 Stocks Moving In Friday's Mid-Day Session
Gainers Image Sensing Systems, Inc. (NASDAQ: ISNS) rose 29.2% to $5.93 after the company announced it initiated a quarterly dividend of $0.12 per share, authorized a 220,000... 
Via Benzinga
55 Biggest Movers From Friday
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) jumped 45.5% to close at $49.80 on Friday after dropping around 22% on Thursday. Brooklyn ImmunoTherapeutics acquired... 
Via Benzinga
Why DexCom Stock Is Dropping Today
Investors were not pleased with the company's latest earnings report. 
Via The Motley Fool
The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) AtriCure, Inc. (NASDAQ:... 
Via Benzinga
< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.